Support for research on infectious diseases and antibiotic resistance
Biocontainment Research Support Service(s) Core
['FUNDING_OTHER'] · UNIVERSITY OF CHICAGO · NIH-10910210
This study is all about finding better ways to understand and handle infectious diseases that could be a threat to our safety, and it’s designed for researchers who want to improve how we diagnose and treat these illnesses, which could ultimately help patients like you.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF CHICAGO (nih funded) |
| Locations | 1 site (CHICAGO, UNITED STATES) |
| Trial ID | NIH-10910210 on ClinicalTrials.gov |
What this research studies
This research focuses on providing essential services for studying and managing infectious diseases, particularly those that pose a biodefense threat. The project aims to isolate and characterize dangerous pathogens, develop animal models for infection studies, and offer specialized training for researchers working with these agents. By collaborating with a network of laboratories, the initiative ensures a comprehensive approach to emerging health threats, enhancing preparedness and response capabilities. Patients may benefit indirectly through advancements in diagnostics and treatments stemming from this research.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit include individuals at risk for emerging infectious diseases or those involved in biodefense research.
Not a fit: Patients with non-infectious diseases or those not involved in research related to infectious diseases may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved methods for diagnosing and treating infectious diseases, ultimately enhancing public health safety.
How similar studies have performed: Previous research in biodefense and infectious disease management has shown success in improving response strategies and treatment options.
Where this research is happening
CHICAGO, UNITED STATES
- UNIVERSITY OF CHICAGO — CHICAGO, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: MISSIAKAS, DOMINIQUE M. — UNIVERSITY OF CHICAGO
- Study coordinator: MISSIAKAS, DOMINIQUE M.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.